TROV Key Stats
- Nasdaq stocks posting largest percentage increases May 20
- Nasdaq stocks posting largest percentage increases May 16
- Organovo: Get Rich Or Die Tryin' May 15
- TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Conditio... May 15
- Trovagene (TROV) Tops Q1 EPS by 2c Street Insider May 14
- Trovagene, Inc. Announces First Quarter 2013 Earnings PR Newswire May 14
- TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report May 14
- The 4 Healthcare Companies Investors Should Be Watching May 14
- Weekly Stock Watch - Week Of May 13, 2013 May 11
- Detecting Investment Potential In Medical Diagnostics Companies May 7
TROV Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). TrovaGene is up 18.88% over the last year vs S&P 500 Total Return up 28.33%, Oramed Pharmaceuticals down 97.13%, and Tesaro up 1.04%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for TROV
Pro Report PDF for TROV
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download TROV Pro Report PDF
Pro Strategies Featuring TROV
Did TrovaGene make it into our Pro Portfolio Strategies?